PRECISIONheor’s Post

Register for this live webinar where subject matter experts discuss the market, challenges, and forecast. #medtech #cardiology

The uptake of pulsed field ablation (PFA) for atrial fibrillation treatment has far exceeded many expectations, but like other groundbreaking innovations, it will be crucial for stakeholders in this space to navigate an evolving regulatory landscape, financial considerations, and other complexities. My Clarivate colleagues, Pankhil Gandhi, Annette Marie Boyle, Dee Chaudhary, BA MBA, and Juliane Ray, will discuss these dynamics in an upcoming webinar on September 26th 11am ET. Tune in to learn more!

Excited to be part of an insightful discussion on Pulsed Field Ablation (PFA) and the evolving landscape of cardiac ablation technologies! Join us for a webinar on September 26th as we explore the challenges of financial uncertainties, regulatory shifts, and global adoption of groundbreaking treatments like PFA. 🗓️ September 26 | 8 AM PT | 10 AM CT | 11 AM ET | 8:30 PM IST #Medtech #PulsedFieldAblation #CardiacAblation #HealthcareInnovation #Webinar #MedicalDevices #Clarivate

𝗦𝗮𝗻𝗼 𝗣𝗿𝗼𝗱𝘂𝗰𝘁 𝗦𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁 ✨ From start to finish, Sano's technology simplifies the precision medicine research process for both sponsors and participants. In the newest webinar from Sano Genetics, Clare Clarke explores the details of our participant-focused design and its role in transforming the clinical trial experience. 🚀 Discover our latest technology in the first of a series dedicated to our products. 👇 https://lnkd.in/eZ5DC-aY #ClinicalTrials #PrecisionMedicine

What's driving the future of diagnostics? We’ve got the answers! Our 2023 report explores the advancements and hurdles in the diagnostics industry. Curious about what’s coming next? Learn about the key technologies, top challenges, and biggest opportunities shaping patient outcomes for years to come. See what’s on the horizon for diagnostics: https://lnkd.in/exR_MRv8 #MolecularDiagnostics #DiagnosticsTrends #HealthcareInnovation #MedicalTechnology

The latest trends in the diagnostic industry are ushering in an era of innovation. As the industry learns to consistently navigate coverage and reimbursement, the push for advanced diagnostics is enabling healthcare providers to tailor treatments to specific variants. This advancement is not only improving patient outcomes but also enhancing the precision of medicine. Join industry experts Elliott Greenspan, CIO and Co-Founder, @Igentify, Lishan Aklog, MD, Chairman and CEO, Lucid Diagnostics, Rollie Carlson, Ph.D. Carlson, CEO, Immunexpress Inc. Inc and Mike Ward, Head of Thought Leadership for Life Sciences & Healthcare, Clarivate, as they discuss these innovations. https://lnkd.in/ea76Ckak #MedTech #Diagnostics

Signify Research Ltd's newest report, 'Digital Precision Medicine - World - 2024' is now published! This is a topical report Alexandra Bream and I have written on the impact of precision medicine on healthcare stakeholder strategies and provider purchasing behaviours. The study is designed to answer questions such as: 1. What are different healthcare technology vendors' strategies across precision medicine? 2. What areas of healthcare are vendors prioritising for future R&D? 3. Which emerging markets which support precision medicine will be the next growth driver?  4. Is funding being allocated to these areas by customers? Companies profiled in the research include Brainomix, VIDA, Quibim, Perspectum Ltd, Tempus AI, Illumina, QIAGEN, SOPHiA GENETICS, PrediSurge, Sim&Cure, Twin Health and Q Bio. If you'd like to know more or arrange a complimentary briefing for an overview of the report's contents, click the link below to download the brochure and get in touch: #healthcaremarketintelligence #digitaltwins #theranostics #realworlddaa #aibiomarkers #digitalcompaniondiagnostics

Join EY and AdvaMed for this insightful webinar on the current state of the medtech industry and where it’s headed. Webinar will take place on December 12, 2023. Fresh off the publication of the EY Pulse of the Industry medtech report and our panel discussions at The MedTech Conference, EY is back with a new webcast, Advancing Medtech’s Digital Opportunity to Meet the Moment. From financial performance heading into 2024 to new therapies such as GLP-1, AI’s impact on innovation, the voice of the customer, digital care delivery and much more, we’ll take a deep dive into the state of the industry and where it’s headed. Topics Include: Financial performance heading into 2024 New therapies such as GLP-1 AI’s impact on innovation The voice of the customer Digital care delivery #lifesciences #biotechnology #artificialintelligenceforbusiness #medtechinnovation #artificialintelligencetechnology #lifescience #digitalbusinesstransformation

Ready to explore business models in digital health? Join my colleagues for the Zühlke Health Talk where industry experts from Roche Diagnostics and Gerresheimer will share insights on how Pharma and MedTech companies can overcome the challenge of selecting the right digital health business models and measure their impact. Find out more: https://lnkd.in/dWGXVJQ7

Biotech and medtech companies today are navigating evolving market dynamics and compliance requirements. In this @IDC white paper, learn how cloud-based solutions can transform back-office operations, streamline workflows, and unlock scalable growth. https://lnkd.in/dAMUjXJn